Returned cognition after quinacrine in patients with Creutzfeldt-Jakob disease

被引：0
|
作者：
Nakajima, M
Yamada, T
Kusuhara, Y
Furukawa, H
Takahashi, M
Kataoka, Y
Doh-Ura, K
机构：
来源：
ANNALS OF NEUROLOGY | 2002年 / 52卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S68 / S68
页数：1
相关论文
共 50 条
  • [1] Results of quinacrine administration to patients with Creutzfeldt-Jakob disease
    Nakajima, M
    Yamada, T
    Kusuhara, T
    Furukawa, H
    Takahashi, M
    Yamauchi, A
    Kataoka, Y
    [J]. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2004, 17 (03) : 158 - 163
  • [2] Experimental therapy with quinacrine in Creutzfeldt-Jakob disease
    Puoti, G.
    Giaccone, G.
    Tagliavini, F.
    De Angelis, G.
    Rossi, R.
    Limido, L.
    Tucci, C.
    Mangieri, M.
    Cotrufo, R.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2004, 11 : 40 - 40
  • [3] Quinacrine treatment trial for sporadic Creutzfeldt-Jakob disease
    Geschwind, Michael D.
    Kuo, Amy L.
    Wong, Katherine S.
    Haman, Aissa
    Devereux, Gillian
    Raudabaugh, Benjamin J.
    Johnson, David Y.
    Torres-Chae, Charles C.
    Finley, Ron
    Garcia, Paul
    Thai, Julie N.
    Cheng, Hugo Q.
    Neuhaus, John M.
    Forner, Sven A.
    Duncan, Jacque L.
    Possin, Katherine L.
    DeArmond, Stephen J.
    Prusiner, Stanley B.
    Miller, Bruce L.
    [J]. NEUROLOGY, 2013, 81 (23) : 2015 - 2023
  • [4] Clinical, neuropathological analysis of administration of quinacrine in Creutzfeldt-Jakob disease
    Satoh, K.
    Shirabe, S.
    Eguchi, K.
    [J]. JOURNAL OF NEUROLOGY, 2006, 253 : 96 - 96
  • [5] What could be the role of quinacrine in Creutzfeldt-Jakob disease treatment?
    Zawada, Z.
    Sebestik, J.
    Safarik, M.
    Krejcirikova, A.
    Hlavacek, J.
    Stibor, I.
    Holada, K.
    Bour, P.
    [J]. JOURNAL OF PEPTIDE SCIENCE, 2010, 16 : 55 - 55
  • [6] Sporadic Creutzfeldt-Jakob disease with worsening depression and cognition
    Muayqil, Taim
    Siddiqi, Zaeem A.
    [J]. CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2007, 34 (04) : 464 - 466
  • [7] Sporadic Creutzfeldt-Jakob disease mimicking variant Creutzfeldt-Jakob disease
    Martindale, J
    Geschwind, MD
    De Armond, S
    Young, G
    Dillon, WP
    Henry, R
    Uyehara-Lock, JH
    Gaskin, DA
    Miller, BL
    [J]. ARCHIVES OF NEUROLOGY, 2003, 60 (05) : 767 - 770
  • [8] Genetic Creutzfeldt-Jakob disease mimicking variant Creutzfeldt-Jakob disease
    Kovacs, G. G.
    Horvath, S.
    Stroebel, T.
    Puskas, M.
    Bakos, A.
    Summers, D. M.
    Will, R. G.
    Budka, H.
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2009, 80 (12): : 1410 - 1411
  • [9] Treatment with anti-malaria agents, quinacrine and quinine, for Creutzfeldt-Jakob disease patients
    Tsuboi, Y
    Fujiki, F
    Yamauchi, A
    Katsumi, D
    Kataoka, Y
    Yamada, T
    [J]. Prions: Food and Drug Safety, 2005, : 267 - 268
  • [10] Quinacrine does not prolong survival in a murine Creutzfeldt-Jakob disease model
    Collins, SJ
    Lewis, V
    Brazier, M
    Hill, AF
    Fletcher, A
    Masters, CL
    [J]. ANNALS OF NEUROLOGY, 2002, 52 (04) : 503 - 506
12345